Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Health Canada Approval
Recent news which mentions Health Canada Approval
From The U.S. To Canada: High-Quality Psilocybin API Gets Green Light For Import
June 12, 2023
Tags
Health Canada Approval
Psychedelic/Assisted Therapies
Drug Enforcement Agency
From
Benzinga
Optimi Health Boosts Psilocybin Production With New Health Canada License And Supply Deal
May 11, 2023
Tickers
OPTHF
Tags
News
Good Manufacturing Practices
Markets
From
Benzinga
Health Canada Grants Exemption: Phase 2 Trial On Psilocybin For Genetic Disorder
February 14, 2023
Tickers
KONEF
NMLSF
Tags
KONEF
Psilocybin program
Psilocybin Microdosing
From
Benzinga
This Psychedelic-Assisted Therapy Study Offers Therapists Experience With Magic Mushroom Tea
February 01, 2023
Tickers
NUMIF
Tags
Psychedelics
Benzinga
Market News
From
Benzinga
Psychedelics Update: MDMA Export, 3D Farm, Recovery Center Reopens, Mushroom Extraction & E-Commerce
January 24, 2023
Tickers
PSYCF
PSYGF
TRUFF
Tags
Psilocybin program
Ibogaine
Cannabis
From
Benzinga
Here Are The Latest Psychedelics Partnerships From Production & Supply Chain To Community Action
January 21, 2023
Tickers
AMZN
CLABF
OPTHF
TRUFF
Tags
FDA
This Is Jane Project
Psilocybin Microdosis
From
Benzinga
First-Ever Clinical Trial On Magic Mushroom Therapy For Autism's Genetic Cause Receives Approval
December 27, 2022
Tickers
KONEF
NMLSF
Tags
Cannabis
Fragile X Syndrome
Penny Stocks
From
Benzinga
Psychedelic Partnership To Test Psilocybin For FXS In First Phase 2 Clinical Trial
November 30, 2022
Tickers
KONEF
NMLSF
Tags
psilocybin therapies
KONEF
Market News
From
Benzinga
New Batch Of Psilocybin Microdose Capsules Is Ready, Learn All The Details
September 17, 2022
Tickers
NMLSF
Tags
psilocybin therapies
Health Canada Approval
News
From
Benzinga
Merck Secures Canadian Regulatory Nod For KEYTRUDA In Skin Cancer After Resection
September 13, 2022
Tickers
MRK
Tags
General
Market News
Biotech
From
Benzinga
Bristol Myers Squibb Secures Canadian Regulatory Nod For Lung Cancer Candidate In Neoadjuvant Setting
August 23, 2022
Tickers
BMY
Tags
BMY
Health Canada Approval
Health Care
From
Benzinga
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit